Importantly, our further analysis revealed that SERPINE1 expression was associated with several immune biomarkers, indicating that SERPINE1 may have therapeutic value as a target of immunotherapy for ccRCC. This evidence concerns the gene SERPINE1 and nonpapillary renal cell carcinoma.